Excerpt from Brinknews.com's Article "T-Minus 11 Months for EU Privacy Regulation" by Omer Tene | September 14, 2017Read Article Now
d-Wise's Insight on Brinknews.com's Article
The European Union’s (EU) General Data Protection Regulation (GDPR) is one of the biggest changes to personal privacy and data protection to happen in years. The impact of this legislation will affect organizations worldwide, including any business that does business in the EU, or handles personal information of EU citizens in any way. As privacy shifts from a policy issue handled by legal, to an operational issue requiring sophisticated technology solutions to manage and anonymize personal information, most organizations will need a technology to support their de-identification efforts.
New requirements concerning topics such as Verifiable Consent, The Right to be Forgotten, and Privacy by Design fall within the jurisdiction of both marketing and product departments. Because accountability now goes beyond the legal team, organizations need solutions to verify and demonstrate that GDPR requirements are being met.
For biopharmaceutical organizations interested in anonymizing personal data, d-Wise has developed Blur, an application-based de-identification solution, to apply the emerging rules for de-identification and integrate the execution of these rules into a comprehensive workflow-driven process that provides automated documentation, traceability and audit trails. As an industry solution, Blur will also be updated as de-identification rules evolve and converge, and will provide a modern, superior alternative to the development and use of SAS-based de-identification scripts. If your organization needs help building, implementing, or demonstrating GDPR compliance, d-Wise offers services and solutions to help, no matter where your organization stands on the GDPR requirements.
Register for our webinar: